Literature DB >> 23759528

Transient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits.

Steven B Yee1, David N Dyer, Nancy A Twenhafel, M Louise M Pitt.   

Abstract

Previous studies have demonstrated that prior infection by various bacterial pathogens induces nonspecific resistance to subsequent infection by other gram-negative and gram-positive bacterial pathogens. In the present study, we evaluated whether underlying inflammation enhanced host resistance to inhalational Bacillus anthracis infection in New Zealand White rabbits (SPF; Bordetella- and Pasteurella-free). Accordingly, rabbits were pretreated with either the inflammagen bacterial LPS (60,000 EU/kg), a component of the outer membrane of gram-negative bacteria, or saline (vehicle). Administration of LPS resulted in brief pyrexia and a significant increase in the proinflammatory cytokine TNFα, thus confirming LPS-induced inflammation. At 24 h after LPS treatment, rabbits were exposed to aerosolized B. anthracis spores (Ames strain; approximately 300 LD50). Blood samples collected at various times after challenge were cultured. Compared with their saline-pretreated counterparts, LPS-pretreated, B. anthracis challenged rabbits exhibited delays in 2 biomarkers of B. anthracis infection-anthrax-induced pyrexia (25 h versus 66 h after challenge, respectively) and bacteremia (26 h versus 63 h, respectively)-and survived longer (41 h versus 90 h, respectively). Similar to control animals, all LPS-pretreated, B. anthracis-challenged rabbits exhibited pathology consistent with inhalational anthrax. Taken together, these results suggest that prior or underlying stimulation of the innate immune system induces transient host resistance to subsequent B. anthracis infection in SPF New Zealand white rabbits. In particular, our results emphasize the importance of using animals that are free of underlying infections to prevent confounding data in studies for inhalational anthrax characterization and medical countermeasure evaluation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23759528      PMCID: PMC3690431     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  53 in total

1.  Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection.

Authors:  Christopher K Cote; Nico Van Rooijen; Susan L Welkos
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Cathelicidin administration protects mice from Bacillus anthracis spore challenge.

Authors:  Mark W Lisanby; Melissa K Swiecki; Brian L P Dizon; Kathryn J Pflughoeft; Theresa M Koehler; John F Kearney
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 3.  Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides.

Authors:  J A Hewett; R A Roth
Journal:  Pharmacol Rev       Date:  1993-12       Impact factor: 25.468

4.  Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment.

Authors:  Steven B Yee; Joshua M Hatkin; David N Dyer; Steven A Orr; M Louise M Pitt
Journal:  Comp Med       Date:  2010-12       Impact factor: 0.982

Review 5.  Pathology of inhalational anthrax animal models.

Authors:  N A Twenhafel
Journal:  Vet Pathol       Date:  2010-07-23       Impact factor: 2.221

6.  Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax.

Authors:  Elizabeth K Leffel; James S Bourdage; E Diane Williamson; Matthew Duchars; Thomas R Fuerst; Peter C Fusco
Journal:  Clin Vaccine Immunol       Date:  2012-06-13

7.  The molecular basis of the host response to lipopolysaccharide.

Authors:  Clare E Bryant; David R Spring; Monique Gangloff; Nicholas J Gay
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

8.  Lipopolysaccharide-induced non-specific resistance to systemic Escherichia coli infection in mice.

Authors:  J Vuopio-Varkila; M Nurminen; L Pyhälä; P H Mäkelä
Journal:  J Med Microbiol       Date:  1988-03       Impact factor: 2.472

9.  Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi.

Authors:  Scott E Evans; Brenton L Scott; Cecilia G Clement; Derek T Larson; Dimitrios Kontoyiannis; Russell E Lewis; P Rocco Lasala; Jennifer Pawlik; Johnny W Peterson; Ashok K Chopra; Gary Klimpel; Gabriela Bowden; Magnus Höök; Yi Xu; Michael J Tuvim; Burton F Dickey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-03-27       Impact factor: 6.914

10.  Protection of mice against bacterial infection by oral administration of bacterial lipopolysaccharide.

Authors:  T Fujiki; H Kutsukake; K Imai; A Tanaka
Journal:  Microbiol Immunol       Date:  1988       Impact factor: 1.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.